APEPTICO Initiates Phase I Trial With AP301 In Pulmonary Oedema
Main Category: Respiratory / Asthma Also Included In: Clinical Trials / Drug Trials Article Date: 11 Apr 2011 APEPTICO, a privately-held biotechnology company developing peptide drugs based on its PEPBASE discovery technology, today announced the initiation of a Phase I clinical trial with its lead product AP301 to assess the safety and ...
Join the discussion below, or Read more at MediLexicon.
#1 Apr 12, 2011
Why is all this Pharma propaganda being posted for?
Add your comments below
|You'll never guess how much Brits spend a year ...||Sep '16||Keiragambler||3|
|This Sick 20-Year-Old Wants Her Parents Prosecuted (Apr '16)||Apr '16||Hang um||1|
|can viagra make you go deaf? (Apr '16)||Apr '16||Hewitt||1|
|natalie gregg: viagra and divorce: is there a l... (Mar '16)||Apr '16||Velasquez||2|
|can viagra make you go deaf? (Mar '16)||Apr '16||Travis||3|
|Family remembers late son by giving to local fi... (Mar '16)||Mar '16||Telling the truth||1|
|Sault woman joined by son, moving south for tra... (Jan '16)||Jan '16||Polly||1|
Find what you want!
Search Kidney Cancer Forum Now
Copyright © 2016 Topix LLC